Chromosomal imbalances in small cell carcinomas of the urinary bladder

Journal of Pathology

Volumn 189, Issue 2, 1999, Pages 230-235

  Terracciano, Luigi ^a   Richter, Jan ^a   Tornillo, Luigi ^a   Beffa, Lorenza ^a   Diener, Pierre André ^c   Maurer, Robert ^c   Gasser, Thomas C ^a   Moch, Holger ^a   Mihatsch, Michael J ^a   Sauter, Guido ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c NONE

Author keywords

Chromosome 10q; Comparative genomic hybridization; L myc; Small cell carcinoma; Urinary bladder neoplasm

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ONCOGENE; PRIORITY JOURNAL; SMALL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SMALL CELL; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; HUMANS; MALE; NUCLEIC ACID HYBRIDIZATION; URINARY BLADDER NEOPLASMS;

EID: 0032866607     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199910)189:2<230::AID-PATH407>3.0.CO;2-8     Document Type: Article

References (51)

1. Blomjous C, Schipper N, Baak J, van Galen E, de Voogt H, Mejer C. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma. J Clin Pathol 1988; 41: 21-25.
2. Cramer SF, Aikawa M, Cebelin M. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer 1981; 47: 724-730.
3. Abbas F, Civantos F, Benedetto P, Soloway MS. Small cell carcinoma of the bladder and prostate. Urology 1995; 46: 617-630.
4. Oblon D, Parsons J, Zander D, Wajsman Z. Bladder preservation and durable complete remission of small cell carcinoma of the bladder with systemic chemotherapy and adjuvant radiation therapy. Cancer 1993; 71: 2581-2584.
5. Holmang S, Borghede G, Johansson SL. Primary small cell carcinoma of the bladder: a report of 25 cases. J Urol 1995; 153: 1820-1822.
6. Atkin N, Baker M. Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11. Cancer Genet Cytogenet 1985; 15: 253-268.
7. Kallioniemi A, Kallioniemi O, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
8. Cappellen D, Gil Diez de Medina S, Chopin D, Thiery JP, Radvanyi F. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene 1997; 14: 3059-3066.
9. Kagan J, Liu J, Stein JD, et al. Cluster of allele losses within a 2·5 cM region of chromosome 10 in high-grade invasive bladder cancer. Oncogene 1998; 16: 909-913.
10. Richter J, Beffa L, Wagner U, et al. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 1998; 153: 1615-1621.
11. Hovey R, Chu L, Balazs M, et al. Genetic alterations in primary bladder cancers and their metastases. Cancer Res 1998; 58: 3555-3560.
12. Zervos AS, Gyuris J, Brent R. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 1993; 72: 223-232.
13. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947.
14. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMACl, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 1997; 15: 356-362.
15. Cairns P, Evron E, Okami K, et al. Point mutation and homozygous deletion of PTEN/MMACl in primary bladder cancers. Oncogene 1998; 16: 3215-3218.
16. Knowles MA, Elder PA, Williamson M, Cairns JP, Shaw ME, Law MG. Allelotype of human bladder cancer. Cancer Res 1994; 54: 531-538.
17. Polascik TJ, Cairns P, Chang WY, Schoenberg MP, Sidransky D. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res 1995; 55: 5396-5399.
18. Rosin MP, Cairns P, Epstein JI, Schoenberg MP, Sidransky D. Partial allelotype of carcinoma in situ of the human bladder. Cancer Res 1995; 55: 5213-5216.
19. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res 1994; 54: 4481-4487.
20. Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WK, Steck PA. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene 1997; 14: 369-373.
21. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996; 15: 234-245.
22. Fong KM, Zimmerman PV, Smith PJ. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res 1995; 55: 220-223.
23. Shibagaki I, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res 1994; 54: 2996-3000.
24. Allan GJ, Cottrell S, Trowsdale J, Foulkes WD. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22. Hum Mutat 1994; 3: 283-291.
25. Powell SM, Cummings OW, Mullen JA, et al. Characterization of the APC gene in sporadic gastric adenocarcinomas. Oncogene 1996; 12: 1953-1959.
26. Okamoto M, Sato C, Kohno Y, et al. Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis. Hum Genet 1990; 85: 595-599.
27. Miyamoto H, Shuin T, Torigoe S, Iwasaki Y, Kubota Y. Retinoblastoma gene mutations in primary human bladder cancer. Br J Cancer 1995; 71: 831-835.
28. Cordon-Cardo C, Wartinger D, Petrylak D, et al. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst 1992; 84: 1251-1256.
29. Gaynor RB, Muchardt C, Xia YR, et al. Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter. Genomics 1991; 10: 1100-1102.
30. Gaynor RB, Muchardt C, Diep A, Mohandas TK, Sparkes RS, Lusis AJ. Localization of the zinc finger DNA-binding protein HIV-EP1/MBP-1/ PRDII-BF1 to human chromosome 6p22.3-p24. Genomics 1991; 9: 758-761.
31. Motokura T, Yi HF, Kronenberg HM, McBride OW, Arnold A. Assignment of the human cyclin D3 gene (CCND3) to chromosome 6p-q13. Cytogenet Cell Genet 1992; 61: 5-7.
32. Masters JR, Vesey SG, Munn CF, Evan GI, Watson JV. c-myc oncoprotein levels in bladder cancer. Urol Res 1988; 16: 341-344.
33. Sauter G, Carroll P, Moch H, et al. Increased c-myc gene copy number in advanced bladder cancer. Am J Pathol 1995; 146: 1131-1139.
34. Kotake T, Saiki S, Kinouchi T, Shiku H, Nakayama E. Detection of the c-myc gene product in urinary bladder cancer. Jpn J Cancer Res 1990; 81: 1198-1201.
35. Kallioniemi A, Kallioniemi O, Citro G, et al. Identification of novel DNA amplifications and deletions in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995; 12: 213-219.
36. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998; 17: 3052-3065.
37. Anzick S, Kononen J, Walker R, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997; 277: 965-968.
38. Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 1107-1123.
39. van Hoeven K, Artymyshyn R. Cytology of small cell carcinoma of the urinary bladder. Diagn Cytopathol 1996; 14: 292-297.
40. Richter J, Jiang F, Görög J, et al. Marked genetic differences between pTa and pTl papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997; 57: 2860-2864.
41. Levin N, Brzoska P, Gupta N, Minna J, Gray J, Christman M. Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res 1994; 54: 5086-5091.
42. Petersen I, Langreck H, Wolf G, et al. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 1997; 75: 79-86.
43. Testa J, Liu Z, Feder M, et al. Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet 1997; 95: 20-32.
44. Kinzler KW, Zehnbauer BA, Brodeur GM, et al. Amplification units containing human N-myc and c-myc genes. Proc Natl Acad Sci U S A 1986; 83: 1031-1035.
45. Saksela K, Bergh J, Lehto VP, Nilsson K, Alitalo K. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Cancer Res 1985; 45: 1823-1827.
46. Cairns P, Polascik TJ, Eby Y, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genet 1995; 11: 210-212.
47. Voorter C, Joos S, Bringuier PP, et al. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 1995; 146: 1341-1354.
48. Simon R, Bürger H, Brinkschmidt C, Böcker W, Hertle L, Terpe H. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998; 185: 345-351.
49. Cairns P, Shaw ME, Knowles MA. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene 1993; 8: 1083-1085.
50. Ruppert J, Tokino T, Sidransky D. Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 1993; 53: 5093-5095.
51. Spruck CHI, Ohneseit PF, Gonzalez ZM, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994; 54: 784-788.